Northwestern Univ / Infect Dis Div / Pasavant Pav 828 — Chicago, Illinois

Northwestern Univ / Infect Dis Div / Pasavant Pav 828 is a clinical research site located in Chicago, Illinois, United States 60611.

Crixeo Health Trust Score: 55/100 (POOR). This profile has not yet been claimed by the site owner.

Northwestern Univ / Infect Dis Div / Pasavant Pav 828 has participated in 2 clinical trials.

Therapeutic areas: HIV Infections.

Sponsors: Merck Sharp & Dohme LLC, Trimeris.

Sponsor Feasibility Report

Trust Score: 55/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Northwestern Univ / Infect Dis Div / Pasavant Pav 828?

Northwestern Univ / Infect Dis Div / Pasavant Pav 828 has a Crixeo Trust Score of 55/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Northwestern Univ / Infect Dis Div / Pasavant Pav 828 conducted?

Northwestern Univ / Infect Dis Div / Pasavant Pav 828 has 2 clinical trials on record. Their work covers HIV Infections.

Is Northwestern Univ / Infect Dis Div / Pasavant Pav 828 accredited by Crixeo Health?

Northwestern Univ / Infect Dis Div / Pasavant Pav 828 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Northwestern Univ / Infect Dis Div / Pasavant Pav 828?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.